A workshop entitled 'Developmental Immunotoxicology and Risk Assessment' was held on 12-13 June 2001, in Washington, DC.
Developmental Immunotoxicology and Risk Assessment: A Workshop Summary
Human and Experimental Toxicology, 2002
Open access, peer-reviewed publications ensure that knowledge is a public good. HESI believes that accessible research is critical for equitable engagement, diverse collaboration, and increased interdisciplinary conversation. We strive to achieve open access on all publications, and more than 200 publications from HESI programs have been published in the last decade.
Human and Experimental Toxicology, 2002
A workshop entitled 'Developmental Immunotoxicology and Risk Assessment' was held on 12-13 June 2001, in Washington, DC.
Human and Experimental Toxicology, 2002
The laboratory mouse has been the most extensively used model system for demonstrating postnatal immune deficits following perinatal immunotoxicant exposure.
Human and Experimental Toxicology, 2002
Developmental immunotoxicity is new both as an area of scientific study and as a potential source of concern in the protection of the public health.
Human and Experimental Toxicology, 2002
Dogs play an important role in toxicology because of their importance as a large animal, pre-clinical model for evaluating potential toxicity in human drug development including the effects of investigational drugs on the immune system.
Human and Experimental Toxicology, 2002
While the history of immunotoxicology research involving experimental animals of immature ages dates back over several decades, there exist remarkably little data, to date, directly comparing the impact of developmental status on immunotoxicological risk.
Human and Experimental Toxicology, 2002
Macaques are well suited for preclinical testing of biopharmaceutics due to reproductive and developmental similarities with humans.
hesi@hesiglobal.org
Phone: +1-202-659-8404
Fax: +1-202-659-3859
740 15th Street NW, Suite 600
Washington, DC 20005
Sign up for our monthly e-newsletter.